Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group

Koessler, Thibaud; Alsina Maqueda, Maria; Arnold, Dirk; Ben-Aharon, Irit; Lutz, Manfred; Obermannova, Radka

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Koessler, Thibaud
dc.contributor.author	Alsina Maqueda, Maria
dc.contributor.author	Arnold, Dirk
dc.contributor.author	Ben-Aharon, Irit
dc.contributor.author	Lutz, Manfred
dc.contributor.author	Obermannova, Radka
dc.date.accessioned	2022-06-15T11:00:45Z
dc.date.available	2022-06-15T11:00:45Z
dc.date.issued	2021-09
dc.identifier.citation	Koessler T, Alsina M, Arnold D, Ben-Aharon I, Lutz MP, Obermannova R, et al. Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group. Br J Cancer. 2021 Sep;125:911–919.
dc.identifier.issn	1532-1827
dc.identifier.uri	https://hdl.handle.net/11351/7683
dc.description	Biliary tract cancer; Colorectal cancer; Drug development
dc.description.abstract	Last year the field of immunotherapy was finally introduced to GI oncology, with several changes in clinical practice such as advanced hepatocellular carcinoma or metastatic colorectal MSI-H. At the virtual ASCO-GI symposium 2021, several large trial results have been reported, some leading to a change of practice. Furthermore, during ASCO-GI 2021, results from early phase trials have been presented, some with potential important implications for future treatments. We provide here an overview of these important results and their integration into routine clinical practice.
dc.language.iso	eng
dc.publisher	Springer Nature
dc.relation.ispartofseries	British Journal of Cancer;125
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Avaluació de resultats (Assistència sanitària)
dc.subject	Immunoteràpia
dc.subject	Aparell digestiu - Càncer - Tractament
dc.subject.mesh	Gastrointestinal Neoplasms
dc.subject.mesh	/drug therapy
dc.subject.mesh	Immunotherapy
dc.subject.mesh	Treatment Outcome
dc.title	Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1038/s41416-021-01474-y
dc.subject.decs	neoplasias gastrointestinales
dc.subject.decs	/farmacoterapia
dc.subject.decs	inmunoterapia
dc.subject.decs	resultado del tratamiento
dc.relation.publishversion	https://doi.org/10.1038/s41416-021-01474-y
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Koessler T] Department of Oncology, Geneva University Hospital, Geneva, Switzerland. Swiss Cancer Center Leman (SCCL), University of Geneva, Lausanne, Switzerland. European Organisation for Research and Treatment of Cancer, Brussel, Belgium. [Alsina M] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Arnold D] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Department of Oncology, Haematology and Palliative Care, Asklepios Klinik Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany. [Ben-Aharon I] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Division of Oncology, Rambam Health Care Campus, Rappaport Faculty of Medicine, Technion, Haifa, Israel. [Lutz MP] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Caritasklinikum, Saarbrucken, Germany. [Obermannova R] European Organisation for Research and Treatment of Cancer, Brussel, Belgium. Department of Comprehensive Cancer Care, Masaryk Memorial Cancer Institute and Faculty of Medicine, Masaryk University, Brno, Czech Republic. Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
dc.identifier.pmid	34426663
dc.identifier.wos	000687550400002
dc.rights.accessrights	info:eu-repo/semantics/openAccess